HopeStage
Back to all studies
SuspendedNCT05121428

Patients' Attitudes Toward and Experiences With Buprenorphine Treatment

Observational studyAges 18+United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: from 18 years.

Listed locations
CambridgeSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: November 20, 2021
Recruitment status
Suspended
Enrollment listed in the registry
817
Sponsor
Cambridge Health Alliance
Sponsor type
Unknown or unclear
Study type
Observational
Intervention type
Interview / survey / observational
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT05121428
Official title
Show the full official title

Exploring the Attitudes and Experiences of Patients Engaged in Buprenorphine Treatment During the COVID-19 Pandemic

Recruitment & locations

Suspended

Cambridge

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Cambridge Health Alliance.

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as suspended.

Want to explore more studies?

Explore studies